Literature DB >> 3260952

In vivo and in vitro evidence of B cell hyperactivity during Lyme disease.

L H Sigal1, A C Steere, J M Dwyer.   

Abstract

In vitro IgM production by cells from patients with Lyme disease rose during the illness in those studied soon after onset, but fell from elevated levels in those initially studied later than 1 week after onset. Borrelia burgdorferi stimulated normal and patients' cells produced IgM, with cells from acutely ill patients producing the most; production fell during convalescence. Patients with active Lyme disease and those destined for later manifestations often had serum agglutinins for heterologous red blood cells. Thus, there is in vitro and in vivo B cell hyperactivity in Lyme disease caused by B. burgdorferi. Both mitogenic and antigenic stimulation of B cells may induce the humoral response seen in complicated Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260952

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

Review 2.  Childhood Lyme borreliosis in Europe.

Authors:  H I Huppertz
Journal:  Eur J Pediatr       Date:  1990-09       Impact factor: 3.183

3.  Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice.

Authors:  L Yang; Y Ma; R Schoenfeld; M Griffiths; E Eichwald; B Araneo; J J Weis
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

4.  Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.

Authors:  K F Tai; Y Ma; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.

Authors:  L Yang; J H Weis; E Eichwald; C P Kolbert; D H Persing; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.

Authors:  Y Ma; J J Weis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Specific and nonspecific responses of murine B cells to membrane blebs of Borrelia burgdorferi.

Authors:  W M Whitmire; C F Garon
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification.

Authors:  J J Weis; Y Ma; L F Erdile
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi.

Authors:  R Schoenfeld; B Araneo; Y Ma; L M Yang; J J Weis
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.